Prospective evaluation of perioperative biochemical investigations to predict hypocalcemia after total or near total thyroidectomy

Mohammad Farooque; Viraj Narola; Dixit Prajapati; Tushar Patel

doi:10.53730/ijhs.v6nS8.13907

Authors

Mohammad Farooque Assistant Professor, Department of General Surgery, Sumandeep Vidyapeeth, Pipariya
Viraj Narola Resident in Department of General Surgery, Sumandeep Vidyapeeth, Pipariya
Dixit Prajapati Assistant Professor, Department of General Surgery, Sumandeep Vidyapeeth, Pipariya
Tushar Patel Assistant Professor, Department of General Surgery, Sumandeep Vidyapeeth, Pipariya

Keywords:

thyroidectomy, hypocalcemia, fibroblastic growth factor-23, diagnosis

Abstract

Hypocalcemia is one of the common complications after total thyroidectomy. In these patients, the serum parathyroid hormone (PTH), calcium level decreases, and the phosphorus level increases. The level of fibroblast growth factor-23 (FGF-23), a phosphaturic hormone, increases in the serum to normalize the serum phosphorus level. In our study, we aimed to investigate the predictive values of PTH, calcium, phosphorus, 1,25-dihydroxy vitamin D (vitamin D), and FGF-23 tests in revealing patients who will develop hypocalcemia after thyroidectomy. Fifty-seven patients undergoing total thyroidectomy (fifty-two with multinodular goiter, three with Graves’ disease and two with papillary thyroid cancer) were included in this prospective study. Serum PTH, calcium, phosphorus, and vitamin D levels of the patients were measured preoperatively. Ten minutes after complete removal of the thyroid gland, intraoperative PTH (IOPTH) level was measured and the amount of decline in PTH level (PTH decline) was calculated. Postoperative PTH, calcium, phosphorus, vitamin D, and FGF-23 levels were measured 24 h after the operation. Postoperatively, hypocalcemia developed in 7(12.3%) of the 57 patients. IOPTH, postoperative PTH, calcium, and vitamin D levels were significantly lower and PTH decline was significantly higher in patients with postoperative hypocalcemia. Postoperative FGF-23 levels were similar between the groups (p 0.952).

Downloads

Download data is not yet available.

References

Alía P, Moreno P, Rigo R et al (2007) Postresection parathyroid hormone and parathyroid hormone decline accurately predict hypocalcemia after thyroidectomy. Am J Clin Pathol 127(4):592–597

Cho JN, Park WS, Min SY (2016) Predictors and risk factors of hypoparathyroidism after total thyroidectomy. Int J Surg 34:47–52

David V, Dai B, Martin A, Huang J, Han X, Quarles LD (2013) Calcium regulates FGF-23 expression in bone. Endocrinology 154(12):4469–4482

Erbil Y, Barbaros U, Temel B et al (2009) The impact of age, vitamin D(3) level, and incidental parathyroidectomy on postoperative hypocalcemia after total or near total thyroidectomy. Am J Surg 197(4):439–446

Gracia-Iguacel C, Gonzalez-Parra E, Rodriguez-Osorio L, Sanz AB, Almaden Y, de la Piedra C, Egido J, Rodriguez M, Ortiz A (2013) Correction of hypocalcemia allows optimal recruitment of FGF-23-dependent phosphaturic mechanisms in acute hyperphosphatemia post-phosphate enema. J Bone Miner Metab 31:703–707

Grodski S, Serpell J (2008) Evidence for the role of perioperative PTH measurement after total thyroidectomy as a predictor of hypocalcemia. World J Surg 32(7):1367–1373

Gulluoglu B, Manukyan MN, Cingi A et al (2005) Early prediction of normocalcemia after thyroid surgery. World J Surg 29:1288– 1293

Gupta A, Winer K, Econs MJ, Marx SJ, Collins MT (2004) FGF-23 is elevated by chronic hyperphosphatemia. J Clin Endocrinol Metab 89(9):4489–4492

Hermann M, Ott J, Promberger R, Kober F, Karik M, Freissmuth M (2008) Kinetics of serum parathyroid hormone during and after thyroid surgery. Br J Surg 95(12):1480–1487

Hosseni M, Otaghyar HA, Tizmaghz A et al (2016) Evaluating the time interval for presenting the signs of hypocalcemia after thyroidectomy. J Clin Diagn Res 10(3):19–22

Kalyoncu D, Gönüllü D, Gedik ML et al (2013) Analysis of the factors that have an effect on hypocalcemia following thyroidectomy. UlusCerrahiDerg 29(4):171–176

Mace LM, Gravesen E, Nordholm A et al (2018) Fibroblast growth factor (FGF) 23 regulates the plasma levels of parathyroid hormone ın vivo through the FGF receptor in normocalcemia, but not in hypocalcemia. Calcif Tissue Int 102:85–92

Marcinkowska M, Sniecikowska B, Zygmunt A, Brzezinski J, Dedecjus M, Lewinski A (2017) Postoperative hypoparathyroidism in patients after total thyroidectomy–retrospective analysis. Neuroendocrinol Lett 38(7):488–494

Paek SH, Lee YM, Min SY, Kim SW, Chung KW, Youn YK (2013) Risk factors of hypoparathyroidism following total thyroidectomy for thyroid cancer. World J Surg 37(1):94–101

Pisanu A, Saba A, Coghe F, Uccheddu A (2013) Early prediction of hypocalcemia following total thyroidectomy using combined intact parathyroid hormone and serum calcium measurement. Langenbeck's Arch Surg 398(3):423–430

Stedman T, Chew P, Truran P, Lim CB, Balasubramanian SP (2018) Modification validation and implementation of a protocol for postthyroidectomy hypocalcaemia. Ann R Coll Surg Engl 100:135–139

Wiseman JE, Mossanen M, Ituarte PH et al (2010) An algorithm in formed by the parathyroid hormone level reduces hypocalcemic complications of thyroidectomy. World J Surg 34(3):532–537

Yamashita H, Yamazaki Y, Hasegawa H et al (2007) Fibroblast growth factor-23 (FGF-23) in patients with transient hypoparathyroidism: its important role in serum phosphate regulation. Endocr J 54(3):465–470

Yamashita H, Yamazaki Y, Hasegawa H, Yamashita T, Fukumoto S, Shigematsu T, Kazama JJ, Fukagawa M, Noguchi S (2005) Fibroblast growth factor-23 in patients with Graves’ disease before and after antithyroid therapy: its important role in serum phosphate regulation. J Clin Endocrinol Metab 90(7):4211–4215